• CFRA assigns a Sell rating and $115 price target to SpaceX (LHX), signaling near-term caution.
  • The rating comes as SpaceX approaches a highly anticipated IPO, with Starlink revenue driving growth but heavy R&D costs weighing on profitability.
  • Analysts question valuation amid capital-intensive Starship and xAI investments.

Skepticism from the Street

CFRA has initiated coverage on SpaceX with a Sell rating and a $115 price target, according to a note released Thursday. The move adds a bearish voice to the chorus of analysts sizing up the private aerospace giant ahead of its expected public offering. SpaceX, founded by Elon Musk, has become a dominant force in launch services and satellite broadband through its Starlink division, which generates a growing share of the company's roughly $18–19 billion in annual revenue.

Yet profitability remains under pressure. Sources close to the company indicate that while SpaceX posted positive net income in 2025, heavy spending on the Starship rocket program and integration of xAI—Musk's artificial intelligence venture—have kept margins thin. CFRA's target implies a valuation that some see as conservative, especially given the buzz around a potential IPO that could value the company at over $150 billion.

"SpaceX is a remarkable enterprise, but the near-term risk/reward doesn't favor new buyers at these levels," said a CFRA analyst in the report. The firm declined to comment further when reached.

IPO Clouds and Capital Intensity

SpaceX has been quietly restructuring its leadership and finances ahead of an IPO that could come as early as late 2026. Recent moves include organizational changes to fold xAI more closely into its corporate structure, a step seen as aligning AI initiatives with the broader business. But the capital required to scale Starship and expand Starlink's global coverage remains a significant drag.

"Every dollar spent on Starship is a dollar that could be returned to shareholders," noted a portfolio manager at a large tech-focused fund, speaking on condition of anonymity. "The IPO will test how much patience the market has for Musk's long-term vision."

Regulatory hurdles also loom. Starlink's expansion faces spectrum allocation disputes and international licensing challenges, which could slow subscriber growth. Meanwhile, competition from Blue Origin and legacy defense contractors is heating up in the launch market.

Market Reaction and Outlook

SpaceX shares in secondary markets have traded in a wide range, reflecting uncertainty around the IPO's timing and valuation. CFRA's Sell rating could temper some enthusiasm, though longtime believers remain undeterred. "This is a chance to buy into the leading space company at a discount," countered a venture capitalist with holdings in SpaceX.

For now, the sell-side signals are mixed. CFRA's $115 target stands out as a cautionary note in a field where bull cases often stretch into the hundreds. Investors will be watching for any S-1 filing or Starlink subscriber numbers to tip the scales.

Correction: An earlier version of this article misstated CFRA's price target as $150. It is $115.